About Syngene
Syngene is a company based in Bengaluru (India) founded in 1993.. Syngene has raised $85.89 million across 3 funding rounds from investors including Goldman Sachs, Morgan Stanley and GE Capital. The company has 8,230 employees as of March 31, 2024. Syngene has completed 1 acquisition, including Strand Life Sciences. Syngene operates in a competitive market with competitors including Abzena, Patheon, Piramal Group, Maravai Life Sciences and LakePharma, among others.
- Headquarter Bengaluru, India
- Employees 8230 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Syngene International Ltd.
-
Annual Revenue
$424.77 M (USD)4.31as on Mar 31, 2024
-
Net Profit
$57.94 M (USD)-2.71as on Mar 31, 2024
-
EBITDA
$123.25 M (USD)-2.58as on Mar 31, 2024
-
Total Equity Funding
$85.89 M (USD)
in 3 rounds
-
Latest Funding Round
$131.23 M (USD), Post-IPO
Feb 02, 2023
-
Investors
Goldman Sachs
& 7 more
-
Employee Count
8230
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Syngene
Syngene is a publicly listed company on the NSE with ticker symbol SYNGENE in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Syngene
Syngene has successfully raised a total of $85.89M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $131.23 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $131.2M
-
First Round
First Round
(01 Oct 2012)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Post-IPO - Syngene | Valuation |
investors |
|
| Sep, 2014 | Amount | Private Equity Round - Syngene | Valuation | True North |
|
| Oct, 2012 | Amount | Private Equity Round - Syngene | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Syngene
Syngene has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Morgan Stanley and GE Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sovereign wealth is managed and private equity investments are facilitated.
|
Founded Year | Domain | Location | |
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location | |
|
Investment strategies are provided across diverse asset classes and markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Syngene
Syngene has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Strand Life Sciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Syngene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Syngene Comparisons
Competitors of Syngene
Syngene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Piramal Group, Maravai Life Sciences and LakePharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Syngene
Frequently Asked Questions about Syngene
When was Syngene founded?
Syngene was founded in 1993 and raised its 1st funding round 19 years after it was founded.
Where is Syngene located?
Syngene is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Syngene?
Jonathan Hunt is the current CEO of Syngene.
Is Syngene a funded company?
Syngene is a funded company, having raised a total of $85.89M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $23.24M, raised on Oct 01, 2012.
How many employees does Syngene have?
As of Mar 31, 2024, the latest employee count at Syngene is 8,230.
What is the annual revenue of Syngene?
Annual revenue of Syngene is $424.77M as on Mar 31, 2024.
What does Syngene do?
Syngene was founded in 1993 in Bengaluru, India, as a provider of contract research and manufacturing in the biotechnology sector. Discovery services are extended across small molecules, large molecules, antibody-drug conjugates, and oligonucleotides. Biological operations encompass recombinant DNA engineering, cell line development, protein sciences, assay biology, DMPK, in vivo pharmacology, and toxicology. Synthetic and medicinal chemistry support is integrated with biological and DMPK elements for comprehensive solutions.
Who are the top competitors of Syngene?
Syngene's top competitors include Abzena, Grand River Aseptic Manufacturing and Patheon.
Is Syngene publicly traded?
Yes, Syngene is publicly traded on NSE under the ticker symbol SYNGENE.
How many acquisitions has Syngene made?
Syngene has made 1 acquisition, including Strand Life Sciences.
Who are Syngene's investors?
Syngene has 8 investors. Key investors include Goldman Sachs, Morgan Stanley, GE Capital, Caisse de depot et placement du Quebec, and GIC.
What is Syngene's ticker symbol?
The ticker symbol of Syngene is SYNGENE on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.